Northern Trust Corp Mannkind Corp Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Mannkind Corp stock. As of the latest transaction made, Northern Trust Corp holds 2,569,992 shares of MNKD stock, worth $18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,569,992
Previous 2,499,598 2.82%
Holding current value
$18 Million
Previous $13 Million 23.7%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$5.01 - $6.7 $352,673 - $471,639
70,394 Added 2.82%
2,569,992 $16.1 Million
Q2 2024

Aug 14, 2024
SELL
$4.05 - $5.43 $349,069 - $468,011
-86,190 Reduced 3.33%
2,499,598 $13 Million
Q1 2024

May 14, 2024
SELL
$3.25 - $5.27 $192,712 - $312,489
-59,296 Reduced 2.24%
2,585,788 $11.7 Million
Q4 2023

Feb 13, 2024
BUY
$3.34 - $4.29 $315,773 - $405,589
94,543 Added 3.71%
2,645,084 $9.63 Million
Q3 2023

Nov 13, 2023
BUY
$3.91 - $5.45 $116,909 - $162,955
29,900 Added 1.19%
2,550,541 $10.5 Million
Q2 2023

Aug 11, 2023
BUY
$3.72 - $4.79 $476,022 - $612,942
127,963 Added 5.35%
2,520,641 $10.3 Million
Q1 2023

May 15, 2023
SELL
$3.95 - $5.63 $143,076 - $203,929
-36,222 Reduced 1.49%
2,392,678 $9.81 Million
Q4 2022

Feb 13, 2023
BUY
$3.02 - $5.37 $280,648 - $499,034
92,930 Added 3.98%
2,428,900 $12.8 Million
Q3 2022

Nov 14, 2022
SELL
$2.99 - $4.35 $44,266 - $64,401
-14,805 Reduced 0.63%
2,335,970 $7.22 Million
Q2 2022

Aug 12, 2022
SELL
$2.67 - $4.77 $70,701 - $126,309
-26,480 Reduced 1.11%
2,350,775 $8.96 Million
Q1 2022

May 13, 2022
SELL
$2.62 - $4.45 $2.17 Million - $3.68 Million
-826,711 Reduced 25.8%
2,377,255 $8.75 Million
Q4 2021

Feb 08, 2022
BUY
$4.05 - $5.37 $347,546 - $460,821
85,814 Added 2.75%
3,203,966 $14 Million
Q3 2021

Nov 15, 2021
SELL
$3.89 - $5.48 $460,062 - $648,108
-118,268 Reduced 3.65%
3,118,152 $13.6 Million
Q2 2021

Aug 13, 2021
BUY
$3.61 - $5.45 $2.94 Million - $4.43 Million
813,190 Added 33.56%
3,236,420 $17.6 Million
Q1 2021

May 12, 2021
SELL
$3.14 - $6.14 $324,396 - $634,329
-103,311 Reduced 4.09%
2,423,230 $9.5 Million
Q4 2020

Feb 11, 2021
SELL
$1.79 - $4.04 $29,737 - $67,116
-16,613 Reduced 0.65%
2,526,541 $7.91 Million
Q3 2020

Nov 16, 2020
BUY
$1.56 - $2.08 $436,687 - $582,250
279,928 Added 12.37%
2,543,154 $4.78 Million
Q2 2020

Aug 14, 2020
BUY
$0.94 - $2.21 $38,961 - $91,600
41,448 Added 1.87%
2,263,226 $3.96 Million
Q1 2020

May 14, 2020
BUY
$0.84 - $1.76 $41,148 - $86,215
48,986 Added 2.25%
2,221,778 $2.29 Million
Q4 2019

Feb 14, 2020
SELL
$1.14 - $1.49 $13,060 - $17,070
-11,457 Reduced 0.52%
2,172,792 $2.8 Million
Q3 2019

Nov 13, 2019
BUY
$1.04 - $1.44 $250,072 - $346,253
240,454 Added 12.37%
2,184,249 $2.73 Million
Q2 2019

Aug 13, 2019
BUY
$1.09 - $1.88 $58,696 - $101,238
53,850 Added 2.85%
1,943,795 $2.24 Million
Q1 2019

May 13, 2019
BUY
$1.14 - $2.25 $357,383 - $705,361
313,494 Added 19.89%
1,889,945 $3.72 Million
Q4 2018

Feb 12, 2019
SELL
$1.02 - $2.05 $46,220 - $92,893
-45,314 Reduced 2.79%
1,576,451 $1.67 Million
Q3 2018

Nov 14, 2018
BUY
$1.01 - $2.19 $81,749 - $177,258
80,940 Added 5.25%
1,621,765 $2.97 Million
Q2 2018

Aug 14, 2018
BUY
$1.59 - $2.38 $2.1 Million - $3.15 Million
1,321,977 Added 604.06%
1,540,825 $2.93 Million
Q1 2018

May 09, 2018
BUY
$2.28 - $3.8 $33,226 - $55,377
14,573 Added 7.13%
218,848 $499,000
Q4 2017

Feb 14, 2018
BUY
$2.28 - $6.71 $48,940 - $144,030
21,465 Added 11.74%
204,275 $474,000
Q3 2017

Nov 13, 2017
BUY
$1.15 - $2.29 $210,231 - $418,634
182,810
182,810 $397,000

Others Institutions Holding MNKD

# of Institutions
244
Shares Held
147M
Call Options Held
1.61M
Put Options Held
789K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email